Novartis – MPP, Nilotinib, Non-Exclusive License Agreement Post author:GHIAA Admin Post published:October 17, 2024 Post category: Continue ReadingNovartis – MPP, Nilotinib, Non-Exclusive License Agreement
MPP – Biovac, mRNA Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:October 8, 2024 Post category: Continue ReadingMPP – Biovac, mRNA Vaccine Technology Transfer Agreement
Wellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement Post author:GHIAA Admin Post published:October 7, 2024 Post category: Continue ReadingWellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement
Gates Foundation – Amyris, Inc., Malaria Therapeutic (artemisinin-based combination therapies – ACTs), Letter Agreement Post author:GHIAA Admin Post published:September 12, 2024 Post category: Continue ReadingGates Foundation – Amyris, Inc., Malaria Therapeutic (artemisinin-based combination therapies – ACTs), Letter Agreement
CEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement Post author:GHIAA Admin Post published:September 2, 2024 Post category: Continue ReadingCEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement
Adjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement Post author:GHIAA Admin Post published:August 26, 2024 Post category: Continue ReadingAdjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
NIAID – AbCellera, COVID-19 Exclusive Patent License Agreement Post author:GHIAA Admin Post published:April 11, 2024 Post category: Continue ReadingNIAID – AbCellera, COVID-19 Exclusive Patent License Agreement